US Bancorp DE Trims Stake in Anthem (ANTM)

US Bancorp DE cut its stake in shares of Anthem (NYSE:ANTM) by 4.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,660 shares of the company’s stock after selling 2,951 shares during the quarter. US Bancorp DE’s holdings in Anthem were worth $13,328,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ANTM. Viking Global Investors LP boosted its stake in shares of Anthem by 190.5% during the 4th quarter. Viking Global Investors LP now owns 2,537,576 shares of the company’s stock worth $570,980,000 after acquiring an additional 1,664,112 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Anthem by 66.0% during the 4th quarter. Allianz Asset Management GmbH now owns 1,603,619 shares of the company’s stock worth $360,830,000 after acquiring an additional 637,439 shares in the last quarter. Farallon Capital Management LLC boosted its stake in shares of Anthem by 291.9% during the 4th quarter. Farallon Capital Management LLC now owns 823,000 shares of the company’s stock worth $185,183,000 after acquiring an additional 613,000 shares in the last quarter. Vulcan Value Partners LLC boosted its stake in shares of Anthem by 52.1% during the 4th quarter. Vulcan Value Partners LLC now owns 1,327,283 shares of the company’s stock worth $298,652,000 after acquiring an additional 454,892 shares in the last quarter. Finally, HealthCor Management L.P. bought a new stake in shares of Anthem during the 4th quarter worth $71,144,000. 88.27% of the stock is owned by institutional investors and hedge funds.

In other Anthem news, CEO Brian T. Griffin sold 59,421 shares of the firm’s stock in a transaction dated Thursday, May 3rd. The stock was sold at an average price of $224.41, for a total transaction of $13,334,666.61. Following the transaction, the chief executive officer now directly owns 25,619 shares in the company, valued at $5,749,159.79. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert L. Dixon, Jr. sold 1,000 shares of the firm’s stock in a transaction dated Friday, May 18th. The shares were sold at an average price of $231.10, for a total value of $231,100.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 135,264 shares of company stock valued at $30,794,160. 0.31% of the stock is owned by corporate insiders.



Shares of NYSE:ANTM opened at $231.87 on Friday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.67. Anthem has a 1 year low of $174.96 and a 1 year high of $267.95. The firm has a market cap of $59.17 billion, a P/E ratio of 19.26, a PEG ratio of 1.29 and a beta of 0.87.

Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, April 25th. The company reported $5.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.83 by $0.58. Anthem had a return on equity of 12.77% and a net margin of 4.60%. The business had revenue of $22.34 billion during the quarter, compared to analyst estimates of $22.55 billion. During the same period last year, the company earned $4.68 earnings per share. Anthem’s quarterly revenue was up .1% compared to the same quarter last year. analysts anticipate that Anthem will post 15.38 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 25th. Investors of record on Friday, June 8th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.29%. Anthem’s dividend payout ratio is 24.92%.

Several equities research analysts have recently weighed in on ANTM shares. Zacks Investment Research raised Anthem from a “hold” rating to a “buy” rating and set a $252.00 price objective for the company in a research note on Monday, April 9th. Cantor Fitzgerald reissued a “buy” rating and set a $275.00 price objective on shares of Anthem in a research note on Wednesday, April 25th. ValuEngine raised Anthem from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Cowen reaffirmed a “buy” rating and issued a $280.00 target price on shares of Anthem in a research report on Wednesday, January 31st. Finally, Morgan Stanley raised their target price on Anthem from $266.00 to $269.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 26th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $249.00.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem (NYSE:ANTM).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply